Humana Hitting the Mark with Kindred at Home
Hospice News
APRIL 27, 2022
Eight months after closing, Humana’s (NYSE: HUM) $5.7 billion acquisition of Kindred at Home is bearing fruit. The company has seen significant growth in its home health business and is on the cusp of divesting the hospice segment at a sizable valuation. Earlier this month the company signed a definitive agreement to sell a 60% stake in Kindred to the private equity firm Clayton, Dubilier & Rice (CDR) for $2.8 billion.
Let's personalize your content